Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 95D74 | — |
a pediatric dose of Engerix-B was given to an adult patient; a pediatric dose of Engerix-B was given to an adult patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 47-year-old female patient who received HBV (Engerix B pediatric) (batch number 95D74, expiry date 28-MAR-2025) for prophylaxis. On 24-FEB-2025, the patient received Engerix B pediatric. On 24-FEB-2025, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: a pediatric dose of Engerix-B was given to an adult patient) and adult use of a child product (Verbatim: a pediatric dose of Engerix-B was given to an adult patient). The outcome of the underdose and adult use of a child product were not applicable. Additional Information: GSK Receipt Date : 05-MAR-2025 Nurse called on March 5, 2025 to report on February 24, 2025 a pediatric dose of Engerix-B was given to an adult patient which led to adult use of a child product and underdose.